Top Markets
Coin of the day
Anatara Lifesciences Ltd Anatara Lifesciences Ltd

Anatara Lifesciences Ltd

ANR
Rangering i aksjer #37961
Anatara Lifesciences Ltd is an Australian enterprise focused on researching,... Anatara Lifesciences Ltd is an Australian enterprise focused on researching, developing, and commercializing scientifically-validated therapies for digestive system ailments affecting both humans and animals. Its product portfolio includes Gastrointestinal ReProgramming (GRP), a proprietary blend combining bromelain with other evidence-based ingredients, specifically formulated to target the underlying issues of human gastrointestinal conditions such as irritable bowel syndrome and inflammatory bowel disease. The firm also offers 3FDC, designed to address anxiety, stress, or depression. In the animal health sector, Anatara provides Detach for treating diarrhea in piglets, BONIFF as an enhanced dry feed formulation for weaned piglets, and ANR-pf, a unique additive for poultry drinking water. This company was founded in 2010 and is headquartered in Carlton, Australia.
Aksjekurs
$0.00634756
Sist synkronisert: 2026-08-14
Markedsverdi
$1.32M
Endring (1 dag)
0.00%
Endring (1 år)
39.40%
Land
AU
Handel Anatara Lifesciences Ltd (ANR)

Kategori

Antall utestående aksjer for Anatara Lifesciences Ltd (ANR)
Antall utestående aksjer per August 2026: 0
Ifølge Anatara Lifesciences Ltd sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av August 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Anatara Lifesciences Ltd (ANR) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
253.90M -
US
62.19M -
NL
- -
CH
- -
KR
0.00 -
BE